Search Results 741-750 of 17698 for corticosteroid

1. Study to Determine the Effectiveness and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

   Treatment with swallowed topical corticosteroids within 8 weeks prior to baseline. ... Note: One-time use of a corticosteroid as a part of the anesthetic ...

2. Study Treating Patients with Relapsed or Refractory Aggressive B-cell Lymphomas Using Nivolumab with or without Varlilumab - Mayo Clinic

   ... corticosteroids, should be excluded; these include but are not limited to patients with a history of immune related neurologic disease, multiple sclerosis ...

3. Testing the Addition of an Anti-cancer Drug, ASTX727, to Chemotherapy (Paclitaxel) and Immunotherapy (Pembrolizumab) for Metastatic Triple-Negative Breast Cancer - Mayo Clinic

   ... corticosteroids, or ... Replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, ...

4. Biopsy recommended for patients with clinical characteristics of IgG4-ROD

   "Corticosteroid dependency with noninflamed eyes is not typical of GO and should lead the clinician to consider IgG4-ROD . Histologically, GO does not show ...

5. A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - Mayo Clinic

   * Oral corticosteroid (OCS; prednisone or equivalent) background therapy is permitted but not required. For participants taking OCS, the dose must be stable ...

6. Publications - Drew N. Rosenbaum, M.D. - Mayo Clinic

   Corticosteroid therapy in cardiac sarcoidosis is an independent risk factor for the development of venous thromboembolism Journal of the American College of ...

7. Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis - Mayo Clinic

   Unchanged dose of immunosuppressive medications other than oral corticosteroids for ≥ 8 weeks before Screening. Willing to not start or stop any ...

8. Analysis of Group 2 Innate Lymphoid Cells in Peripheral Blood - Mayo Clinic

   Oral corticosteroids or high-dose inhaled corticosteroids in the past 6 weeks before enrollment; On any biologics treatment; A lower or upper airway infection ...

9. Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study - Mayo Clinic

   - More than 1 prior cycle of a antimyeloma therapy or corticosteroids for the treatment of multiple myeloma. - NOTE: Prior corticosteroid use for the treatment ...

10. A Study of Sonidegib and Pembrolizumab in Advanced Solid Tumors - Mayo Clinic

    No corticosteroid use for brain metastases for ≥ 2 weeks before randomization;; ≥ 8 weeks from completion of definitive treatment for brain metastases. Any ...